News dynamics
Hubei Province: All Hospitals Above Grade II Purchase Consumables Online at the End of the Year

Hubei Province: All Hospitals Above Grade II Purchase Consumables Online at the End of the Year

A few days ago, Hubei Province issued the notice on the special rectification work plan for outstanding problems in the field of pharmaceutical purchase and sale in the province, which will carry out a four-month special rectification in the province's health and family planning system to standardize the purchase and sale of drugs and high-value consumables, strictly implement the online procurement of drugs as the focus, and reduce the burden of patients seeing a doctor. The ''Notice'' pointed out that the rectification work will focus on the offline purchase of drugs by medical and health institutions, the online sunshine purchase of high-value medical consumables by medical institutions above the second level that do not follow the regulations, and the illegal purchase, sale, and use of drugs, medical devices, Medical consumables and other behaviors

2015-08-26

View Details
It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.

It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.

Medical Network, August 26-the State Health and Family Planning Commission and the State Food and Drug Administration recently jointly issued China's first "measures for the Administration of Stem Cell Clinical Research", which standardizes the institutional qualifications and conditions of stem cell clinical research. and explicitly prohibit the publication of stem cell clinical research advertisements, limit a number of measures to protect the rights and interests of patients. Data show that it is estimated that by 2016, the market size of the domestic stem cell industry will reach 100 billion yuan. Some people in the industry believe that with the announcement of the management measures, the stem cell industry, especially in the field of treatment, will usher in spring. Stem cell research has a clear tendency to pursue profits. Stem cells are a class of stem cells with self-

2015-08-26

View Details
Food and Drug Administration Launches 2015 National Safe Drug Use Month

Food and Drug Administration Launches 2015 National Safe Drug Use Month

The Food and Drug Administration of all provinces, autonomous regions, and municipalities directly under the Central Government, and the Food and Drug Administration of Xinjiang Production and Construction Corps: According to the requirements of the "National Food and Drug Safety Science Popularization Action Plan (2011-2015)", the "National Safe Drug Month" (Hereinafter referred to as safety month). In order to effectively carry out this year's safety month activities, the relevant matters are hereby notified as follows: the 1. time is arranged from September 1 to October 31, 2015. 2. publicity focuses on publicizing and implementing the "Opinions of the State Council on Reforming the Review and Approval System for Drugs and Medical Devices" (Guo Fa [2015] No. 44

2015-08-26

View Details
The cost of using genetically modified yeast to make painkillers in the United States is expected to be reduced by 10 times.

The cost of using genetically modified yeast to make painkillers in the United States is expected to be reduced by 10 times.

Yeast can be used not only to make steamed bread, but also to make painkillers. Recently, a study published in "Science" introduced a method of using genetically modified yeast to produce morphine-based painkillers. The researchers said that the method can not only shorten the production cycle of drugs from a year to a few days, but also reduce the cost to one tenth of the traditional method. When the technology matures in the future, it is expected to greatly reduce the retail price of related drugs.

2015-08-26

View Details
Pharmaceutical August 2015 report: focus on the reform of state-owned enterprises in the pharmaceutical industry

Pharmaceutical August 2015 report: focus on the reform of state-owned enterprises in the pharmaceutical industry

The market plunged sharply in July, with all sectors falling sharply. Among them, the relatively small decline is the agriculture, forestry, animal husbandry and fishing, defense and military industry sector, followed by banking, leisure services and mining sector. In July, small-cap stocks fell more, while large-cap stocks fell relatively small. Although the pharmaceutical industry has a certain increase, but in view of China is about to enter an aging society, coupled with the performance support of pharmaceutical stocks, investors are still optimistic about pharmaceutical stocks, so the decline of pharmaceutical stocks is not large. And the pharmaceutical industry may have a good follow-up, investors can still be optimistic about the pharmaceutical industry.

2015-08-26

View Details
Global pharmaceutical sales will reach $1.3 trillion in 2018

Global pharmaceutical sales will reach $1.3 trillion in 2018

Thomson Reuters annual CMRFactbook pointed out that 46 new molecular entities were approved for listing in developed countries in 2014, which is far higher than the number in any year since 2005. At the same time, 2014 was also a year of outstanding sales, with $1 trillion. The sales of the United States challenged those who had a negative attitude towards the pharmaceutical industry.

2015-08-26

View Details
New drug development in China: How close are we to the first original drug?

New drug development in China: How close are we to the first original drug?

According to a data provided by the Tufts Center for Drug Development Research, the average cost of developing a new drug is about $2.6 billion. In 2013, the R & D investment of the world's top ten pharmaceutical companies accounted for 17.8 percent of sales, up to $60.39 billion, while the R & D investment of the top ten domestic pharmaceutical companies was only 1% of sales, about $0.3 billion.

2015-08-26

View Details
Antidepressant modafinil, or become the first "smart drug"

Antidepressant modafinil, or become the first "smart drug"

Modafinil (Modafinil), as an antidepressant drug for the treatment of sleep disorders such as narcolepsy, was approved by the US Food and Drug Administration (FDA) in 1998. Modafinil became the first marketed drug for the treatment of sleep disorders with good central excitatory effects and fewer side effects. Past studies have found that people who are sleep-deprived take modafinil and their mental state is significantly enhanced. But for normal people, modafinil this effect is not obvious. And modafinil can be used as an auxiliary drug for the treatment of depression to enhance the therapeutic effect. It is precisely because modafinil has

2015-08-26

View Details
< 1...5678 >